908 Devices Inc. Stock Price, News & Analysis

908 Devices (Nasdaq: MASS) sold 23 MX908 handheld mass spectrometers to the United States Coast Guard on October 28, 2025, bringing total Coast Guard fielded MX908 units to more than 35.

The MX908 uses high-pressure mass spectrometry (HPMS) to identify trace levels of narcotics, explosives and hazardous chemicals in solids, liquids, vapors and aerosols, supporting Coast Guard narcotics interdiction, hazardous incident response, port security and boarding missions.

The devices aim to give frontline units rapid, on-scene chemical identification to inform safety and operational decisions.

908 Devices (Nasdaq: MASS) will report third-quarter 2025 financial results before market open on November 10, 2025. Management will host a live webcast and conference call on November 10, 2025 at 8:30 a.m. ET / 5:30 a.m. PT. Live audio will be available on the company's Investors webpage at www.908devices.com, and the webcast will be archived for replay within 24 hours after the event.

908 Devices (Nasdaq: MASS) announced on October 16, 2025 that the United States Marine Corps CBRNE Installation and Protection Program purchased 17 XplorIR handheld gas-identification devices.

The devices will be deployed at Marine Corps installations in the United States and overseas to identify and quantify hazardous gases and vapors, and to support CBRNE and hazardous materials response for federal firefighters, military police, post offices and security augmentation forces.

The XplorIR detects more than 5,000 gas and vapor threats, uploads samples wirelessly to 908 Devices’ Team Leader app for real-time viewing outside hot zones, and complements the Corps’ earlier adoption of the company’s MX908 handheld mass spectrometer for trace-level identification.

908 Devices (NASDAQ: MASS) reported strong Q2 2025 financial results, with total revenue reaching $13.0 million, up 14% year-over-year. The company's recurring revenue grew 28% to $4.7 million, representing 36% of total revenues.

Key operational highlights include record XplorIR device placements, the launch of VipIR analyzer, and the completion of manufacturing consolidation. The company also acquired KAF Manufacturing for $2.75 million and secured a $6.6 million OEM supply commitment. The installed base grew 27% to 3,336 devices.

Despite posting a net loss of $12.9 million, 908 Devices raised its 2025 revenue outlook to $54-56 million, representing 13-17% growth. The company maintains a strong balance sheet with $118.6 million in cash and no debt.

908 Devices (NASDAQ:MASS), a pioneer in handheld chemical analysis devices, has appointed Dr. Brandi Vann to its Board of Directors. Dr. Vann brings over 15 years of experience from the U.S. Department of Defense, where she served as Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense.

The appointment comes as part of the company's strategic refocus on public health, safety, and defense technology. Simultaneously, Jeff George has stepped down from the Board. Dr. Vann's extensive experience includes leadership roles at the Defense Threat Reduction Agency and oversight of critical defense programs.

908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has announced its participation in the Canaccord Genuity 45th Annual Growth Conference. The company's management team will deliver a presentation on Wednesday, August 13 at 1:00 PM Eastern Time. Investors can access both the live and archived versions of the presentation through the investor relations section of 908 Devices' website.

908 Devices (NASDAQ:MASS), a company specializing in handheld chemical analysis tools for health, safety, and defense applications, has scheduled its second quarter 2025 financial results announcement for August 5, 2025, before market open.

Management will host a conference call and webcast at 8:30 AM ET to discuss the results. Investors can access the live webcast through the company's website at www.908devices.com, with a replay available within 24 hours after the event.

908 Devices (NASDAQ:MASS) has launched VipIR, a groundbreaking 3-in-1 handheld chemical analyzer designed for field-based identification of unknown bulk substances. The device features Smart Spectral Processing (SSP), a proprietary algorithm that integrates both Raman and FTIR spectroscopy technologies into a single workflow.

VipIR includes an extensive library of over 39,000 chemical spectra and is equipped with built-in Wi-Fi and cellular connectivity. The device is specifically designed for customs, border personnel, and hazardous response teams to identify narcotics, explosives, and toxic chemicals efficiently in the field.

908 Devices (NASDAQ:MASS) partnered with Asylon Robotics to deploy gas-detecting security robots at the 2025 Indianapolis 500, the world's largest single-day sporting event with over 300,000 attendees. The collaboration featured Asylon's DroneDog-2 units equipped with 908 Devices' InterceptIR sensor for real-time air monitoring and surveillance.

The autonomous robots, built on Boston Dynamics' Spot® platform, successfully navigated GPS-denied tunnels beneath the track, maintaining operations through secure mesh communications and Starlink backup. The integration with Asylon's DroneIQ software provided emergency personnel with continuous access to live video, threat alerts, and gas detection readings.